DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
SGS-742 is an investigational drug.
There have been 3 clinical trials for SGS-742. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Sclerosis, Lupus Erythematosus, Systemic, and Motor Neuron Disease. The leading clinical trial sponsors are University of Bari, Azienda Ospedaliero-Universitaria di Modena, and GlaxoSmithKline.
Recent Clinical Trials for SGS-742
|Colchicine for Amyotrophic Lateral Sclerosis||Catholic University of the Sacred Heart||Phase 2|
|Colchicine for Amyotrophic Lateral Sclerosis||IRCCS National Neurological Institute "C. Mondino" Foundation||Phase 2|
|Colchicine for Amyotrophic Lateral Sclerosis||IRCCS San Raffaele||Phase 2|